Lumos Pharma (LUMO) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free LUMO Stock Alerts $2.99 -0.03 (-0.99%) (As of 12:12 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetingsglobenewswire.com - April 18 at 4:05 PMLumos Pharma’s LUM-201 Receives ‘Buy’ Rating on Strong Market Position and Promising Trial Outcomesmarkets.businessinsider.com - March 21 at 3:59 AMLumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042globenewswire.com - March 20 at 8:00 AMBAT set to sell stake in India's ITC stake as soon as this week, Bloomberg reportssg.news.yahoo.com - March 11 at 2:00 PMLumos Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - March 10 at 9:46 AMLumos Pharma, Inc. (LUMO) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 9 at 1:25 PMLumos Pharma, Inc.: Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Updatefinanznachrichten.de - March 8 at 3:20 PMLumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 8 at 3:20 PMQ4 2023 Lumos Pharma Inc Earnings Calluk.finance.yahoo.com - March 8 at 10:20 AMLUMO Stock Earnings: Lumos Pharma Misses EPS for Q4 2023investorplace.com - March 7 at 11:06 PMLumos Pharma: Q4 Earnings Insightsbenzinga.com - March 7 at 6:58 PMLumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Updateglobenewswire.com - March 7 at 4:01 PMEarnings Preview: Lumos Pharmabenzinga.com - March 6 at 7:48 PMLumos Pharma FY 2023 Earnings Previewmsn.com - March 6 at 7:48 PMAxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of Directorsfinance.yahoo.com - February 28 at 8:03 AMLumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024globenewswire.com - February 26 at 9:00 AMExact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimatesmsn.com - February 21 at 7:58 PMLumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 5 at 9:16 PMLumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 5 at 9:16 PMIs Lumos Pharma (NASDAQ:LUMO) In A Good Position To Invest In Growth?finance.yahoo.com - February 5 at 3:53 PMLumos Pharma Elevates Pitukcheewanont to Medical Chiefmarketwatch.com - January 4 at 8:26 PMLumos Pharma promotes Pisit Pitukcheewanont to chief medical officermsn.com - January 4 at 8:26 PMLumos Pharma Stock (NASDAQ:LUMO) Dividends: History, Yield and Datesbenzinga.com - December 22 at 8:25 AMBullish Outlook: Buy Rating on Lumos Pharma on Promising LUM-201 Trials for Pediatric Growth Deficiencymarkets.businessinsider.com - December 8 at 10:21 AMLumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiencyfinance.yahoo.com - November 21 at 8:51 PMLumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in Novemberfinance.yahoo.com - November 20 at 5:40 PMLumos Pharma Inc LUMOmorningstar.com - November 12 at 8:03 PMAnalysts Are Bullish on Top Healthcare Stocks: Lumos Pharma (LUMO), Rhythm Pharmaceuticals (RYTM)markets.businessinsider.com - November 8 at 8:26 PMStocks to Watch: Robinhood, Kyndryl, Lumos Pharmamarketwatch.com - November 7 at 11:42 PMLumos Pharma Shares Than Double After Hormone Deficiency Trial Meets All Endpointsmarketwatch.com - November 7 at 6:41 PMLumos stock rockets nearly 100% in after-hours trading on study updatesmsn.com - November 7 at 6:41 PMLumos Pharma GAAP EPS of -$1.04 beats by $0.11, revenue of $7Kmsn.com - November 7 at 6:41 PMPromising Results and Buy Rating for Lumos Pharma’s Groundbreaking Growth Hormone Stimulant: LUM-201markets.businessinsider.com - September 26 at 1:30 PMLumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meetingfinance.yahoo.com - September 26 at 1:30 PMLumos Pharma Announced Abstract Accepted for Oral Presentation at the European Society for Paediatric Endocrinology Annual Meetingfinance.yahoo.com - September 14 at 8:49 AMLumos Pharma Announces Participation in Investor Conferences in Septemberfinance.yahoo.com - September 7 at 8:37 PMWhat 7 Analyst Ratings Have To Say About Lumos Pharmamarkets.businessinsider.com - September 6 at 7:35 PMLumos Pharma (LUMO) Price Target Increased by 10.18% to 20.60msn.com - August 31 at 6:51 AMIndependent Panel of Renowned Pediatric Endocrinologists to Discuss Pediatric Growth Hormone Deficiency and the Therapeutic Landscapefinance.yahoo.com - August 22 at 9:31 AMCantor Fitzgerald Maintains Lumos Pharma (LUMO) Overweight Recommendationmsn.com - August 15 at 9:06 PMThe Latest Analyst Ratings for Lumos Pharmamarkets.businessinsider.com - August 15 at 4:06 PMLumos Pharma, Inc.: Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Updatefinanznachrichten.de - August 14 at 8:13 AMOppenheimer Maintains Lumos Pharma (LUMO) Outperform Recommendationmsn.com - August 11 at 6:33 PMLumos Pharma GAAP EPS of -$1.09 misses by $0.02, revenue of $0.53M beats by $0.33Mmsn.com - August 9 at 5:22 PMLumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Updatefinance.yahoo.com - August 9 at 5:22 PMLumos Pharma to Report Second Quarter 2023 Financial Results and Host Conference Call on August 9, 2023finance.yahoo.com - July 26 at 7:33 PMCantor Fitzgerald Reiterates Lumos Pharma (LUMO) Overweight Recommendationmsn.com - July 25 at 9:25 AMLUMO - Lumos Pharma, Inc.au.finance.yahoo.com - July 13 at 8:06 PMLumos Pharma, Inc.: Lumos Pharma Announces Departure of Chief Medical Officerfinanznachrichten.de - June 29 at 8:44 AMLumos Pharma Announces Departure of Chief Medical Officerfinance.yahoo.com - June 28 at 7:20 PM Get Lumos Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LUMO and its competitors with MarketBeat's FREE daily newsletter. Email Address RSVP: Charles Payne’s Cash Flow Workshop (Ad)Are you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies. Register For Free Now! LUMO Media Mentions By Week LUMO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUMO News Sentiment▼0.000.38▲Average Medical News Sentiment LUMO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUMO Articles This Week▼01▲LUMO Articles Average Week Get Lumos Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LUMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Biora Therapeutics News Today CytoMed Therapeutics News Today Cumberland Pharmaceuticals News Today Lisata Therapeutics News Today Oncternal Therapeutics News Today Bullfrog AI News Today Lipocine News Today Benitec Biopharma News Today TherapeuticsMD News Today Flora Growth News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUMO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
